One could argue that virtually everything one does, and does not do, influences thinking and decisions, so where are the boundaries?
TIME: 8 a.m.
EVENT: Health and Human Services Department (HHS); Food and Drug Administration (FDA) (F.R. Page 1384) holds a joint meeting of the Arthritis Advisory Committee and the Drug Safety and Risk Management Advisory Committee to discuss data and analyses published in 2006 or later that are relevant to further understanding the relationship between nonsteroidal anti-inflammatory drugs (NSAIDs) and cardiovascular thrombotic risk that is currently described in NSAID class labeling, February 10-11.
DATE: February 10, 2014
LOCATION: FDA White Oak Campus, 10903 New Hampshire Avenue, Building 31 Conference Center, the Great Room, Room 1503, Silver Spring, Md.
CONTACT: Stephanie Begansky, 301-796-9001, AAC@fda.hhs.gov